报告时间：3月31日下午18:30
报告地点：bw必威西汉姆联官网仙林校区计科楼233报告厅
报告题目：A New Model for Drug Development in Academic Institutions
报告人：Dr. Dennis C. Liotta
美国埃默里大学Samuel Candler Dobbs讲席教授
美国埃默里大学艾滋病研究中心副主任
美国埃默里大学药物研发院院长
美国化学会药物化学快报主编
美国化学会会士，AAAS会士
报告摘要：
Dr. Liotta have created an innovative model model for expediting drug development at research universities. The Emory Institute for Drug Discovery (EIDD) was founded in 2009 to discover therapeutic agents to treat infectious diseases, particularly viral diseases. The EIDD has the personnel, laboratory space and equipment necessary to conduct the key preclinical activities required to bring a drug into clinical development. DRIVE, the “industrial partner” of the EIDD, is organized as a virtual drug development company with a highly experienced management team. As a 501(c) (3) entity, it will be able to in-license attractive development opportunities from Emory or elsewhere on commercially favorable terms. Then, either by using its own seed capital or by raising external funds, it can utilize the EIDD and/or external vendors to move these opportunities quickly and efficiently down the development continuum to meet the critical need for new therapeutic agents to treat emerging infectious disease. DRIVE has been designed to be a selfsustaining entity, i.e., the company can reinvest its earnings from out-licensing or sale of assets in new development opportunities as they emerge.
欢迎本科生们和感兴趣的同学和老师们参加！
